Related Experiment Video
Updated: Jul 11, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
[A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin]
Youn Ho Kim1, Woo Sik Han, Sun Jae Lee
1Department of Internal Medicine, Korea University Medical College, Guro Hospital, Seoul, Korea.
Abstract:
There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN plus ribavirin combination therapy are bone marrow suppression and hemolytic anemia. However, there are few reports of vasculitis occurring during PEG-IFN therapy. We describe a patient who developed vasculitis during the treatment of chronic hepatitis C with PEG-IFN and ribavirin.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis II: Pathophysiology
Inhibitors of Viral Protein Synthesis
Cytomegalovirus Disease
Chronic Pancreatitis II: Collaborative Care
Assessment: